AU:VBS Stock Latest News
Company AnnouncementsFDA Provides Supportive Pre-IND Feedback on Vectus’ VB00043d agoVBS
Company AnnouncementsVectus Biosystems Issues 7.9 Million Unquoted Options in New Class2w agoVBS
Company AnnouncementsVectus Biosystems Secures FDA Pre-IND Pathway for IPF Drug as Cash Position Tightens2w agoVBS
Company AnnouncementsVectus Biosystems Wins Unanimous Shareholder Backing at AGM3w agoVBS
Company AnnouncementsVectus Biosystems sharpens fibrosis focus as VB0004 advances and partnering strategy gains traction3w agoVBS
Company AnnouncementsVectus wins FDA pre-IND green light for VB0004 in IPF1M agoVBSCompany AnnouncementsVectus Biosystems sets virtual AGM to ratify capital raising and board re‑election1M agoVBS
Company AnnouncementsVectus Biosystems Releases 2026 Consolidated Annual Report2M agoVBS
Company AnnouncementsVectus Biosystems Sets Date and Process for 2026 Virtual AGM2M agoVBS
Company AnnouncementsVectus Biosystems Director Converts Options into Shares, Boosting Equity Stake2M agoVBS
Company AnnouncementsVectus Biosystems Issues New Shares to Non-Executive Director Under Incentive Plan2M agoVBS
Company AnnouncementsVectus Biosystems Seeks ASX Quotation for 316,000 New Shares2M agoVBSCompany AnnouncementsVectus Biosystems Swings to Profit as Revenue Soars and Balance Sheet Strengthens2M agoVBS
Company AnnouncementsVectus Biosystems Issues New Shares Under Employee Incentive Plan3M agoVBS
Company AnnouncementsVectus Biosystems Seeks ASX Quotation for Additional Ordinary Shares3M agoVBS
Company AnnouncementsVectus Biosystems bolsters leadership, funding and U.S. regulatory push for fibrosis pipeline3M agoVBS
Company AnnouncementsVectus Biosystems Appoints U.S. Regulatory Agent to Advance IPF Drug VB00044M agoVBS
Company AnnouncementsVectus Biosystems issues new shares to CEO under incentive plan4M agoVBSCompany AnnouncementsVectus Biosystems’ New CEO to Outline Antifibrotic Strategy in Investor Webinar5M agoVBS

